284 related articles for article (PubMed ID: 33087034)
1. Old Drugs with New Tricks: Paradigm in Drug Development Pipeline for Alzheimer's Disease.
Dalvi T; Dewangan B; Das R; Rani J; Shinde SD; Vhora N; Jain A; Sahu B
Cent Nerv Syst Agents Med Chem; 2020; 20(3):157-176. PubMed ID: 33087034
[TBL] [Abstract][Full Text] [Related]
2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
3. Repurposed agents in the Alzheimer's disease drug development pipeline.
Bauzon J; Lee G; Cummings J
Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
5. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
6. Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
Ihara M; Saito S
J Alzheimers Dis; 2020; 74(4):1013-1028. PubMed ID: 32144994
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease.
Padhi D; Govindaraju T
J Med Chem; 2022 May; 65(10):7088-7105. PubMed ID: 35559617
[TBL] [Abstract][Full Text] [Related]
8. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease drug development pipeline: 2022.
Cummings J; Lee G; Nahed P; Kambar MEZN; Zhong K; Fonseca J; Taghva K
Alzheimers Dement (N Y); 2022; 8(1):e12295. PubMed ID: 35516416
[TBL] [Abstract][Full Text] [Related]
10. [Drug Repositioning for Alzheimer's Disease].
Ihara M; Saito S
Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
[TBL] [Abstract][Full Text] [Related]
11. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
12. Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.
Chrétien B; Jourdan JP; Davis A; Fedrizzi S; Bureau R; Sassier M; Rochais C; Alexandre J; Lelong-Boulouard V; Dolladille C; Dallemagne P
Br J Clin Pharmacol; 2021 Jul; 87(7):2830-2837. PubMed ID: 33274491
[TBL] [Abstract][Full Text] [Related]
13. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.
Kim TW
Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
Advani D; Kumar P
ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
[TBL] [Abstract][Full Text] [Related]
15. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?
Séguy L; Groo AC; Malzert-Fréon A
Drug Discov Today; 2022 Jun; 27(6):1575-1589. PubMed ID: 35227886
[TBL] [Abstract][Full Text] [Related]
16. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
Norins LC
J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
[TBL] [Abstract][Full Text] [Related]
18. Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles.
Rampa A; Gobbi S; Belluti F; Bisi A
Curr Med Chem; 2021; 28(12):2305-2327. PubMed ID: 32867634
[TBL] [Abstract][Full Text] [Related]
19. Discovering new treatments for Alzheimer's disease by repurposing approved medications.
Appleby BS; Cummings JL
Curr Top Med Chem; 2013; 13(18):2306-27. PubMed ID: 24059463
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease drug development pipeline: 2020.
Cummings J; Lee G; Ritter A; Sabbagh M; Zhong K
Alzheimers Dement (N Y); 2020; 6(1):e12050. PubMed ID: 32695874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
